Literature DB >> 33617141

Hydroxychloroquine-induced acute generalized exanthematous pustulosis: an adverse reaction to keep in mind during COVID-19 pandemic.

Alba Sánchez-Velázquez1, Jorge Arroyo-Andrés1, Daniel Falkenhain-López1, Jose Luis Rodríguez Peralto2, Pablo Luis Ortiz Romero1, Raquel Rivera Díaz1, Alba Calleja-Algarra1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33617141      PMCID: PMC8013657          DOI: 10.1111/ddg.14354

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


× No keyword cloud information.
  3 in total

1.  Acute generalized exanthematous pustulosis due to hydroxichloroquine.

Authors:  Giulia Odorici; Cecilia Schenetti; Lucrezia Pacetti; Natale Schettini; Alba Gaban; Lucia Mantovani
Journal:  Dermatol Ther       Date:  2022-04-23       Impact factor: 3.858

2.  Acute generalized exanthematous pustulosis: a complication of COVID-19 infection or therapy?

Authors:  Farshid Etaee; Narges Ghanei; Tarek Naguib; Steven Daveluy
Journal:  J Cosmet Dermatol       Date:  2022-04-05       Impact factor: 2.189

Review 3.  Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients.

Authors:  Enriqueta Vallejo-Yagüe; Adrian Martinez-De la Torre; Omar S Mohamad; Shweta Sabu; Andrea M Burden
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.